中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein

文献类型:期刊论文

作者Zheng YT(郑永唐) ; Bi KL(贲昆龙) ; Jin SW(金善炜)
刊名Acta Pharmacol. Sin.
出版日期2000
卷号21期号:2页码:179-0182
ISSN号1671-4083
其他题名具有抗HIV-1活性的新核糖体失活蛋白-栝楼蛋白
通讯作者贲昆龙
英文摘要To determine whether trichobitacin, a novel ribosome-inactivating protein purified from the root tubers of trichosanthes kirlowii, possesses the anti-HIV activity. Methods: the inhibition of syncytial cell formaion induced by human immunodeficiency virus type 1 (HIV-1) was determined under microscope, reduction of HIV-1P24 antigen expression level was measured by ELISA, and decrease in numbers of HIV-1 antigen positive cells in acutely and chronically infected cultures were detected by indirect immunofluorescence assay. Results: Trichobitacin was found to greatly suppres syncytial cell formation induced by HIV-1 and to markedly reduce both expression HIV-1 p24 antigen and the number of HIV-1antigen positive cells in acutely but not chronically HIV-1 infected culture. The median inhibitory concentration (IC^50) in inhibition of syncytial cell formation and HIV antigen positive cells were 5 μg.L-1(95 % confidence limits: 1,3-20 μg.L-1) and 0.09 mg.L-~1(95% confidence limits: 0.011-0.755 mg.L~1), respectively. Conclusion: Trichobitacin is a novel ribosome-inactivating protein with anti-HIV-1activity.
学科主题生命有机化学
收录类别SCI
语种英语
WOS记录号WOS:000085208200014
公开日期2013-03-12
源URL[http://202.127.28.38/handle/331003/24711]  
专题上海有机化学研究所_上海有机化学研究所
推荐引用方式
GB/T 7714
Zheng YT,Bi KL,Jin SW. Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein[J]. Acta Pharmacol. Sin.,2000,21(2):179-0182.
APA 郑永唐,贲昆龙,&金善炜.(2000).Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein.Acta Pharmacol. Sin.,21(2),179-0182.
MLA 郑永唐,et al."Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein".Acta Pharmacol. Sin. 21.2(2000):179-0182.

入库方式: OAI收割

来源:上海有机化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。